Fertility and Autoimmune Progesterone Sensitivity

Progesterone is often called the "pregnancy hormone." It stabilizes the uterine lining, supports implantation, and maintains early pregnancy.

But in rare and complex cases, the immune system may react against progesterone itself — a condition known as autoimmune progesterone sensitivity (sometimes referred to as autoimmune progesterone dermatitis).

While uncommon, this phenomenon can play a role in unexplained infertility, recurrent miscarriage, or unusual cyclical symptoms.

What Is Autoimmune Progesterone Sensitivity?

Autoimmune progesterone sensitivity occurs when the body mounts an immune response to endogenous (naturally produced) or exogenous (supplemental) progesterone.

Instead of recognizing progesterone as a normal hormone, the immune system treats it as a trigger — leading to inflammatory or allergic-type reactions.

Symptoms often occur in the luteal phase of the menstrual cycle (after ovulation), when progesterone levels rise.

Common Symptoms

Because progesterone rises predictably each cycle, symptoms often follow a cyclical pattern:

• Hives or skin rashes
• Eczema flares
• Angioedema (swelling)
• Asthma-like symptoms
• Severe PMS
• Migraines
• Cyclical joint pain
• Rarely, anaphylaxis

Symptoms typically improve when progesterone levels fall at the start of menstruation.

How Could This Affect Fertility?

Progesterone is essential for:

• Preparing the endometrium for implantation
• Modulating immune tolerance to the embryo
• Preventing uterine contractions
• Supporting early placental development

If the immune system reacts negatively to progesterone, it may:

• Disrupt endometrial receptivity
• Increase inflammatory cytokines
• Interfere with implantation
• Contribute to early pregnancy loss

In IVF cycles, some patients report worsening symptoms after starting progesterone supplementation.

The Immune Connection

Successful implantation requires a delicate immune shift toward tolerance. Progesterone normally helps facilitate this process.

In autoimmune progesterone sensitivity, this immune adaptation may be impaired — leading to an inflammatory response rather than tolerance.

This may overlap with other immune-mediated fertility conditions, though the exact mechanisms are still being studied.

How Is It Diagnosed?

Diagnosis can be challenging and often requires careful clinical evaluation.

Clues include:

• Consistent luteal-phase symptom flares
• Reactions to progesterone injections or suppositories
• History of cyclical dermatologic or allergic symptoms
• Recurrent early pregnancy loss without other clear causes

In some cases, allergy testing or supervised progesterone challenge testing may be considered. Collaboration between reproductive specialists and immunologists or allergists is often helpful.

Management Options

Treatment depends on severity and reproductive goals.

Possible approaches may include:

• Antihistamines during the luteal phase
• Corticosteroids in select cases
• Ovulation suppression (to prevent endogenous progesterone production)
• Desensitization protocols under specialist supervision
• Careful selection of progesterone formulation in IVF cycles

Management must be highly individualized.

Is This Common?

No. Autoimmune progesterone sensitivity is rare.

Most fertility patients with luteal symptoms or progesterone concerns do not have this condition.

However, in patients with:

• Recurrent unexplained implantation failure
• Cyclical allergic-type symptoms
• Worsening reactions with progesterone supplementation

It may be worth considering.

The Bigger Picture

Fertility is not only hormonal — it is immunologic.

Progesterone plays a central role in shifting the immune system toward acceptance of pregnancy. When that process is disrupted, outcomes can be affected.

Understanding the intersection between hormones and immune response is especially important in complex or unexplained fertility cases.

The Bottom Line

Autoimmune progesterone sensitivity is an uncommon but important condition that may contribute to implantation challenges or recurrent pregnancy loss in select patients.

If you notice consistent luteal-phase symptoms or adverse reactions to progesterone support, a deeper evaluation may help clarify whether immune-mediated progesterone sensitivity is part of the picture.

In reproductive medicine, even rare diagnoses matter — especially when standard explanations fall short.